The Filing Desk

Beta Bionics vs Sanara MedTech

Beta Bionics BBNX · Sanara MedTech SMTI · Health Care Equipment

Sanara MedTech reported revenue of $103 million in fiscal 2025, about the same as Beta Bionics' $100 million in fiscal 2025. Beta Bionics' revenue grew 53.9% in its latest year, and Sanara MedTech's grew 19.0%. Beta Bionics had an operating margin of -71.5%, against 7.1% at Sanara MedTech. Free cash flow was −$56 million at Beta Bionics and $2 million at Sanara MedTech.

Side by side

Beta BionicsSanara MedTech
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$100M$103M
Revenue growth53.9%19.0%
Revenue growth a year, last 5 years—45.9%
Gross margin55.4%92.7%
Operating margin−71.5%7.1%
Net margin−73.0%−36.4%
Free cash flow−$56M$2M
Free cash flow margin−56.1%2.1%
Return on capital—13.0%
Net debt to EBITDA—2.6x
Dividends and buybacks$0M$0M
Change in diluted share count536.7%1.6%
Last close$13.32$32.67
P/E at the last close——
Insider trades, last 12 monthssold $4.5 million—
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Beta BionicsSanara MedTech
Operating margin
Percent of revenue
Beta BionicsSanara MedTech
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Beta BionicsSanara MedTech

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Beta Bionics and Sanara MedTech pages.